Research coauthored by RTI Health Solutions experts will be presented at the German Cancer Congress (Deutscher Krebskongress).
Health-related quality of life (HRQOL) in patients with advanced gastric, gastroesophageal junction, or esophageal adenocarcinoma cancer (GC/GEJC/EAC): 36-month results of CheckMate 649 nivolumab plus chemotherapy (N+C) vs (C). Elimova E, Wyrwicz L, Chen C, Blum SM, Davenport E, Wang J, Kondo K, Moehler MH. Poster
